Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management
Abstract
:References
- Mercadante, S. The Patient with Difficult Cancer Pain. Cancers 2019, 11, 565. [Google Scholar] [CrossRef] [PubMed]
- Caraceni, A.; Shkodra, M. Cancer Pain Assessment and Classification. Cancers 2019, 11, 510. [Google Scholar] [CrossRef] [PubMed]
- Edwards, H.L.; Mulvey, M.R.; Bennett, M.I. Cancer-Related Neuropathic Pain. Cancers 2019, 11, 373. [Google Scholar] [CrossRef] [PubMed]
- Kurita, G.P.; Sjøgren, P.; Klepstad, P.; Mercadante, S. Interventional Techniques to Management of Cancer-Related Pain: Clinical and Critical Aspects. Cancers 2019, 11, 443. [Google Scholar] [CrossRef] [PubMed]
- Amrhein, V.; Greenland, S.; McShane, B. Scientists rise up against statistical significance. Nature 2019, 567, 305–307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mercadante, S. The benefits of practical clinical trials over traditional randomized clinical trials for opioid management. Expert Rev. Clin. Pharmacol. 2018, 11, 741–742. [Google Scholar] [CrossRef] [PubMed]
- Huang, R.Z.; Jiang, L.H.; Liu, H.L.; Cao, Y.; Ping, M.S.; Li, W.; Xu, Y.; Ning, J.; Chen, Y.Q.; Wang, X.J. Comparative efficacy of therapeutics for chronic cancer pain: A Bayesian network analysis. J. Clin. Oncol. 2019, 37, 1742–1752. [Google Scholar] [CrossRef] [PubMed]
- Staats, P.S.; Yearwood, T.; Charapata, S.G.; Presley, R.W.; Wallace, M.S.; Byas-Smith, M.; Fisher, R.; Bryce, D.A.; Manqieri, E.A.; Lither, R.R.; et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: A randomized controlled trial. JAMA 2004, 291, 63–70. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.T.; Sanderson, C.R.; Xuan, W.; Agar, M. Lidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis. J. Palliat. Med. 2019, 22, 326–334. [Google Scholar] [CrossRef] [PubMed]
- Sjölund, K.F.; Yang, R.; Lee, K.H.; Resnick, M. Randomized study of pregabalin in patients with cancer-induced bone pain. Pain Ther. 2013, 2, 37–48. [Google Scholar] [CrossRef] [PubMed]
- Mishra, S.; Bhatnagar, S.; Goyal, G.; Rana, S.P.; Upadhya, S.P. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am. J. Hosp. Palliat. Care 2012, 29, 177–182. [Google Scholar] [CrossRef] [PubMed]
- Raptis, E.; Vadalouca, A.; Stavropoulou, E.; Argyra, E.; Melemeni, A.; Siafaka, A. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: A prospective, head-to-head, randomized, open-label study. Pain Pract. 2014, 14, 32–42. [Google Scholar] [CrossRef] [PubMed]
- Mercadante, S.; Porzio, G.; Aielli, F.; Ferrera, P.; Codipietro, L.; Lo Presti, C.; Casuccio, A. The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin. J. Pain 2013, 29, 15–19. [Google Scholar] [CrossRef] [PubMed]
- Kane, C.M.; Mulvey, M.R.; Wright, S.; Craigs, C.; Wright, J.M.; Bennett, M.I. Opioids combined with antidepressants or antiepileptic drugs for cancer pain: Systematic review and meta-analysis. Palliat. Med. 2018, 32, 276–286. [Google Scholar] [CrossRef] [PubMed]
- Straube, C.; Derry, S.; Jackson, K.C.; Wiffen, P.J.; Bell, R.; Strassels, S.; Straube, S. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst. Rev. 2014, 9, CD006601. [Google Scholar] [CrossRef] [PubMed]
- Wiffen, P.J.; Wee, B.; Derry, S.; Bell, R.F.; Moore, R.A. Opioids for cancer pain—An overwiew of Cochrane reviews. Cochrane Database Syst. Rev. 2017, 7, CD012592. [Google Scholar] [PubMed]
- Dzierżanowski, T. Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence. Cancers 2019, 11, 129. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mercadante, S. Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management. Cancers 2019, 11, 1005. https://doi.org/10.3390/cancers11071005
Mercadante S. Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management. Cancers. 2019; 11(7):1005. https://doi.org/10.3390/cancers11071005
Chicago/Turabian StyleMercadante, Sebastiano. 2019. "Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management" Cancers 11, no. 7: 1005. https://doi.org/10.3390/cancers11071005
APA StyleMercadante, S. (2019). Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management. Cancers, 11(7), 1005. https://doi.org/10.3390/cancers11071005